Medical Physics, The Ottawa Hospital Cancer Centre, Ottawa, Ontario K1H 8L6, Canada.
Med Phys. 2011 Jan;38(1):179-87. doi: 10.1118/1.3515461.
A novel 4D in vivo dosimetry system (RADPOS), in conjunction with a deformable lung phantom, has been evaluated as a potential quality assurance tool for 4D radiotherapy.
RADPOS detectors, which consist of a MOSFET dosimeter combined with an electromagnetic positioning probe, were placed inside the deformable lung phantom. One detector was positioned directly inside a tumor embedded in the lung phantom and another was positioned inside the lung portion of the phantom, outside the tumor. CT scans were taken with the phantom at three breathing phases, and for each phase, the detector position inside the phantom was read with the RADPOS software and compared to the position as determined from the CT data. These values were also compared to RADPOS measurements taken with the phantom on the couch of a Varian Clinac 6EX linac. The deformable phantom and the RADPOS system were also used in two radiation delivery scenarios: (1) A simulation of a free-breathing delivery and (2) a simulation of an adaptive treatment.
Compared to CT imaging, the RADPOS positional accuracy was found to be better than 2.5 mm. The radial displacement measurements taken in the CT and linac rooms agreed to within an average of (0.7 +/- 0.3) mm. Hence, the system can provide relative displacement measurements in the treatment room, consistent with measurements made in the CT room. For the free-breathing delivery, the total dose reported by RADPOS agreed to within 4% and 5% of the treatment planning doses in the tumor and the lung portion of the phantom, respectively. The RADPOS-measured dose values for the adaptive delivery were within 1.5% of the treatment plan values, which was well within the estimated experimental uncertainties.
This work has shown that the deformable lung phantom-RADPOS system can be an efficient quality assurance tool for 4D radiation therapy.
一种新型的 4D 体内剂量测定系统(RADPOS)与可变形肺体模相结合,已被评估为 4D 放疗的潜在质量保证工具。
RADPOS 探测器由 MOSFET 剂量计和电磁定位探头组成,放置在可变形肺体模内部。一个探测器直接放置在嵌入肺体模中的肿瘤内,另一个探测器放置在肿瘤外的肺部分。对体模进行了三次呼吸相位的 CT 扫描,并使用 RADPOS 软件读取体模内探测器的位置,并与 CT 数据确定的位置进行比较。还将这些值与在瓦里安 Clinac 6EX 直线加速器的治疗床上使用 RADPOS 进行的测量进行了比较。可变形体模和 RADPOS 系统还用于两种放射治疗情况:(1)模拟自由呼吸治疗,(2)模拟适应性治疗。
与 CT 成像相比,RADPOS 的位置精度优于 2.5 毫米。在 CT 和直线加速器房间中进行的径向位移测量结果平均相差(0.7 +/- 0.3)毫米。因此,该系统可以在治疗室中提供相对位移测量,与 CT 室中的测量结果一致。对于自由呼吸治疗,RADPOS 报告的总剂量与肿瘤和肺体模部分的治疗计划剂量分别相差 4%和 5%以内。适应性治疗的 RADPOS 测量剂量值与治疗计划值相差 1.5%以内,这在估计的实验不确定度范围内。
这项工作表明,可变形肺体模-RADPOS 系统可以成为 4D 放射治疗的有效质量保证工具。